Morning Market Movers By: Benzinga via Benzinga April 29, 2014 at 09:43 AM EDT Amicus Therapeutics (NASDAQ: FOLD) climbed 28.26% to $2.36 after the company reported positive 12- and 24-month data from Phase 3 Fabry ... Read More >> Related Stocks: Amicus Therapeutics Banco Santander Brasil S.A. ADR Carbonite Inc Central EUR Med A Cirrus Logic Inc Comscore Inc Kulicke and Soffa Luminex Corp Nokia Corp ADR Novavax Inc